Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cincumol prevents malignant phenotype of colorectal cancer cell line HCT116 via inhibiting PI3K/AKT signaling in vitro.

Acta cirurgica brasileira - 1 Jan 2023

Hu Gaowu, Chen Wenquan, Peng Wei, Huang Zhen, Dong Zhanlin, Cao Yongqing

Abstract excerpt

PURPOSE: Colorectal cancer (CRC) is a common human cancer along with higher incidence and mortality, and this study aimed to identify the effect of cincumol on CRC and its potential mechanisms. METHODS: CRC cell line HCT116 was used as the material. Cell proliferation was evaluated by CCK-8 assay, and cell migration was detected by scratch test and Transwell assay. TUNEL staining assay was used to evaluate cell...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Apoptosis
Share to Cell Line, Tumor
Share to Cell Proliferation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colorectal Neoplasms

Share to HCT116 Cells

Share to Phenotype

Share to Phosphatidylinositol 3-Kinases

Share to Proto-Oncogene Proteins c-akt

Source

Open in PubMed Open full text

Identifiers

PMID: 36651426
DOI: 10.1590/acb371201
PMCID: PMC9839155

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cincumol prevents malignant phenotype of colorectal cancer cell line HCT116 via inhibiting PI3K/AKT signaling in vitro.PMID 36651426Read ↗

Natural products for treating colorectal cancer: A mechanistic reviewSemantic proximity Read ↗

Inhibition and potential treatment of colorectal cancer by natural compounds via various signaling pathwaysSemantic proximity Read ↗

Pathogenesis and treatment of colitis-associated colorectal cancer: Insights from Traditional Chinese MedicineSemantic proximity Read ↗

Pharmacological network-based study on interventional mechanism of Baitouweng Decoction for treatment of colitis-associated cancerSemantic proximity Read ↗

Multi-Targeted Anti-Cancer Mechanisms of Li-Ginseng Powder in Colitis-Associated Colorectal Cancer: Integrating Inflammation, Apoptosis and ImmunitySemantic proximity Read ↗

Nitidine chloride inhibits proliferation and induces apoptosis in colorectal cancer cells by activating the p53 signaling pathwaySemantic proximity Read ↗

A Narrative Review on Therapeutic Potential of Naringenin in Colorectal Cancer: Focusing on molecular and biochemical processesSemantic proximity Read ↗

Alisol A attenuates malignant phenotypes of colorectal cancer cells by inactivating PI3K/Akt signalingSemantic proximity Read ↗

Reactive oxygen species and colorectal cancer.Semantic proximity Read ↗

Gegen Qinlian Decoction acts on colorectal cancer by regulating the gut microbiota and participating in signaling pathways such as PI3K-AktSemantic proximity Read ↗

Network pharmacology and molecular docking to elucidate the mechanism of pulsatilla decoction in the treatment of colon cancerSemantic proximity Read ↗

G9a/GLP inhibitor UNC0642 induces growth arrest in colorectal cancer via induction of ROS generation, coordinated overexpression of GADD genes, and the JNK/p38 MAPK pathwaySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.